Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options.
about
Exercise training in idiopathic pulmonary fibrosis: is it of benefit?Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test.The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trialDeterminants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive.Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.Exercise training in idiopathic pulmonary fibrosis.Respiratory and lower limb muscle function in interstitial lung disease.Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications.Be honest and help me prepare for the future: What people with interstitial lung disease want from education in pulmonary rehabilitation.Does nebulized fentanyl relieve dyspnea during exercise in healthy man?Respiratory muscles in interstitial lung disease: poorly explored and poorly understoodIdentifying decreased diaphragmatic mobility and diaphragm thickening in interstitial lung disease: the utility of ultrasound imagingLong-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.Frailty and maximal exercise capacity in adult lung transplant candidates.High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
P2860
Q26740857-EE600EEF-421A-47DC-9ACC-8066F48150F1Q34071333-3AEF0F71-8252-48E5-96C9-7A3D9500524DQ34569852-8CE44DC1-E506-46F1-A698-B62F717DE0A2Q36734220-B3886E9D-4197-4429-BFBE-0B80F7D54EA8Q37629575-C03E2EE0-70D9-4790-8B1E-151C2FAEF72DQ37656969-B78E9D7E-BA11-476B-AA7B-F89DC5981B14Q38633341-40677071-0E84-4841-9CC5-16E8C8B6CEFFQ38696775-8EE33C41-00F2-4595-98DB-18F9514EF76DQ38837394-C471DF91-58C8-4387-ACF4-F2A90A8A30A4Q39038309-C231CFFF-CD86-442A-A4C0-A09FEF59DD63Q39188413-2F9F4D0F-2ED0-497F-9249-873D67A13062Q40875174-E272B875-3483-43B6-9F7A-2D73975396B5Q40875257-0EDB6AA7-6069-4FD2-A441-B4E2C0709E33Q41322247-63AB10F4-F761-4C4B-8024-B99D5D79D145Q46259645-876AE68F-3D79-48A0-B068-F9EEB2636034Q47615565-63FEBB6F-9C97-4B43-810C-181D77B5254DQ58711431-62308915-6E0D-40AA-8B1F-26D49C0D9EE3
P2860
Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exercise limitation in interst ...... cance and therapeutic options.
@en
Exercise limitation in interst ...... cance and therapeutic options.
@nl
type
label
Exercise limitation in interst ...... cance and therapeutic options.
@en
Exercise limitation in interst ...... cance and therapeutic options.
@nl
prefLabel
Exercise limitation in interst ...... cance and therapeutic options.
@en
Exercise limitation in interst ...... cance and therapeutic options.
@nl
P2860
P356
P1476
Exercise limitation in interst ...... icance and therapeutic options
@en
P2093
Anne E Holland
P2860
P304
P356
10.1177/1479972309354689
P577
2010-01-07T00:00:00Z